Blume Capital Management, Inc. Organon & Co. Transaction History

Blume Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$31.66 - $38.9 $2,944 - $3,617	93 New	93 $3,000
Q4 2021 Feb 07, 2022	SELL	$28.67 - $37.13 $1,146 - $1,485	-40 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $4,867 - $6,058	-170 Reduced 80.95%	40 $1,000
Q2 2021 Aug 10, 2021	BUY	$28.45 - $38.0 $5,974 - $7,980	210 New	210 $6,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.06B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.